461 related articles for article (PubMed ID: 18691555)
21. Yeast two-hybrid detection of integrase-host factor interactions.
Rain JC; Cribier A; Gérard A; Emiliani S; Benarous R
Methods; 2009 Apr; 47(4):291-7. PubMed ID: 19232540
[TBL] [Abstract][Full Text] [Related]
22. Quinoline-based Protein-protein Interaction Inhibitors of LEDGF/p75 and HIV Integrase: An In Silico Study.
Chhokar N; Kalra S; Chauhan M; Munshi A; Kumar R
Curr Top Med Chem; 2018; 18(32):2800-2815. PubMed ID: 30747071
[TBL] [Abstract][Full Text] [Related]
23. Traditional Chinese medicine application in HIV: an in silico study.
Huang HJ; Jian YR; Chen CY
J Biomol Struct Dyn; 2014; 32(1):1-12. PubMed ID: 23252879
[TBL] [Abstract][Full Text] [Related]
24. Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering.
Vanegas M; Llano M; Delgado S; Thompson D; Peretz M; Poeschla E
J Cell Sci; 2005 Apr; 118(Pt 8):1733-43. PubMed ID: 15797927
[TBL] [Abstract][Full Text] [Related]
25. Identification and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF/p75.
Llano M; Vanegas M; Hutchins N; Thompson D; Delgado S; Poeschla EM
J Mol Biol; 2006 Jul; 360(4):760-73. PubMed ID: 16793062
[TBL] [Abstract][Full Text] [Related]
26. Symmetrical 1-pyrrolidineacetamide showing anti-HIV activity through a new binding site on HIV-1 integrase.
Du L; Zhao YX; Yang LM; Zheng YT; Tang Y; Shen X; Jiang HL
Acta Pharmacol Sin; 2008 Oct; 29(10):1261-7. PubMed ID: 18817633
[TBL] [Abstract][Full Text] [Related]
27. Computational studies of the interaction between the HIV-1 integrase tetramer and the cofactor LEDGF/p75: insights from molecular dynamics simulations and the informational spectrum method.
Tintori C; Veljkovic N; Veljkovic V; Botta M
Proteins; 2010 Dec; 78(16):3396-408. PubMed ID: 20878714
[TBL] [Abstract][Full Text] [Related]
28. The selenium-containing drug ebselen potently disrupts LEDGF/p75-HIV-1 integrase interaction by targeting LEDGF/p75.
Zhang DW; Yan HL; Xu XS; Xu L; Yin ZH; Chang S; Luo H
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):906-912. PubMed ID: 32228103
[TBL] [Abstract][Full Text] [Related]
29. [LEDGF/p75: a novel target for anti-HIV therapy and advances in the study of its related inhibitors].
Chen WM; Liu XY
Yao Xue Xue Bao; 2009 Sep; 44(9):953-60. PubMed ID: 20055168
[TBL] [Abstract][Full Text] [Related]
30. In silico virtual screening of potent inhibitor to hamper the interaction between HIV-1 integrase and LEDGF/p75 interaction using E-pharmacophore modeling, molecular docking, and dynamics simulations.
Panwar U; Singh SK
Comput Biol Chem; 2021 Aug; 93():107509. PubMed ID: 34153658
[TBL] [Abstract][Full Text] [Related]
31. Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor.
De Luca L; Ferro S; Gitto R; Barreca ML; Agnello S; Christ F; Debyser Z; Chimirri A
Bioorg Med Chem; 2010 Nov; 18(21):7515-21. PubMed ID: 20850978
[TBL] [Abstract][Full Text] [Related]
32. Hyrtiosal, from the marine sponge Hyrtios erectus, inhibits HIV-1 integrase binding to viral DNA by a new inhibitor binding site.
Du L; Shen L; Yu Z; Chen J; Guo Y; Tang Y; Shen X; Jiang H
ChemMedChem; 2008 Jan; 3(1):173-80. PubMed ID: 17943714
[TBL] [Abstract][Full Text] [Related]
33. Discovery of novel HIV-1 integrase-LEDGF/p75 allosteric inhibitors based on a pyridine scaffold forming an intramolecular hydrogen bond.
Sugiyama S; Akiyama T; Taoda Y; Iwaki T; Matsuoka E; Akihisa E; Seki T; Yoshinaga T; Kawasuji T
Bioorg Med Chem Lett; 2021 Feb; 33():127742. PubMed ID: 33316407
[TBL] [Abstract][Full Text] [Related]
34. Identification of old drugs as potential inhibitors of HIV-1 integrase - human LEDGF/p75 interaction via molecular docking.
Hu G; Li X; Sun X; Lu W; Liu G; Huang J; Shen X; Tang Y
J Mol Model; 2012 Dec; 18(12):4995-5003. PubMed ID: 22733274
[TBL] [Abstract][Full Text] [Related]
35. Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: a scaffold hopping approach using salicylate and catechol groups.
Fan X; Zhang FH; Al-Safi RI; Zeng LF; Shabaik Y; Debnath B; Sanchez TW; Odde S; Neamati N; Long YQ
Bioorg Med Chem; 2011 Aug; 19(16):4935-52. PubMed ID: 21778063
[TBL] [Abstract][Full Text] [Related]
36. Blocking the interaction between HIV-1 integrase and human LEDGF/p75: mutational studies, virtual screening and molecular dynamics simulations.
Reddy KK; Singh P; Singh SK
Mol Biosyst; 2014 Mar; 10(3):526-36. PubMed ID: 24389668
[TBL] [Abstract][Full Text] [Related]
37. Characterization of rare lens epithelium-derived growth factor/p75 genetic variants identified in HIV-1 long-term nonprogressors.
Schrijvers R; Demeulemeester J; De Rijck J; Christ F; Gérard M; Debyser Z; Gijsbers R
AIDS; 2013 Feb; 27(4):539-43. PubMed ID: 23211777
[TBL] [Abstract][Full Text] [Related]
38. Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance.
Lataillade M; Chiarella J; Kozal MJ
Antivir Ther; 2007; 12(4):563-70. PubMed ID: 17668566
[TBL] [Abstract][Full Text] [Related]
39. Cyclic peptide inhibitors of HIV-1 integrase derived from the LEDGF/p75 protein.
Hayouka Z; Hurevich M; Levin A; Benyamini H; Iosub A; Maes M; Shalev DE; Loyter A; Gilon C; Friedler A
Bioorg Med Chem; 2010 Dec; 18(23):8388-95. PubMed ID: 20974536
[TBL] [Abstract][Full Text] [Related]
40. Peptides derived from the HIV-1 integrase promote HIV-1 infection and multi-integration of viral cDNA in LEDGF/p75-knockdown cells.
Levin A; Hayouka Z; Friedler A; Loyter A
Virol J; 2010 Aug; 7():177. PubMed ID: 20678206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
